Heart Patients' genes may hold key to safer blood thinner use
NCT ID NCT06143709
First seen Jan 16, 2026 · Last updated May 23, 2026 · Updated 14 times
Summary
This study tracks over 1600 heart patients who had a stent placed and received genetic testing to help choose their blood thinner medication. The goal is to learn which patients benefit most from genotype-guided therapy and how to reduce risks like heart attack or bleeding. Researchers will follow participants for 12 months and analyze DNA and platelet function in a subset of patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CORONARY ARTERY DISEASE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
University of Florida
Gainesville, Florida, 32609, United States
Conditions
Explore the condition pages connected to this study.